Approval · Notice of Compliance 5246 · 1995
LINSOTALOL: Notice of Compliance 5246
Issued June 13, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5246
- Date
- June 13, 1995
- Company
- Linson Pharma Co.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Antiarrhythmic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LINSOTALOL | 02170833 | Cancelled Post Market |
| LINSOTALOL | 02170841 | Cancelled Post Market |
| LINSOTALOL | 02170868 | — |
| LINSOTALOL | 02170876 | — |
Medicinal ingredients
- SOTALOL HYDROCHLORIDE 80 MG per TAB
- SOTALOL HYDROCHLORIDE 160 MG per TAB
- SOTALOL HYDROCHLORIDE 240 MG per TAB
- SOTALOL HYDROCHLORIDE 320 MG per TAB